Retour
Fourchette du Jour
13,76 €
14,10 €
Fourchette 52 Semaines
9,53 €
19,85 €
Volume
2 691 374
Moyenne 50J / 200J
16,87 €
/
15,41 €
Clôture Précédente
13,50 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 50,6 | 0,4 |
| P/B | 6,5 | 2,9 |
| ROE % | 15,4 | 3,7 |
| Net Margin % | 6,7 | 3,9 |
| Rev Growth 5Y % | 5,7 | 10,0 |
| D/E | 3,8 | 0,2 |
Objectif de Cours des Analystes
Hold
22,67 €
+63.3%
Low: 20,00 €
High: 24,00 €
P/E Prévisionnel
14,4
BPA Prévisionnel
0,96 €
Croissance BPA (est.)
+0,0%
CA Est.
1,2 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
1,29 €
1,28 € – 1,30 €
|
1,5 B | 1 |
| FY2028 |
1,17 €
1,08 € – 1,26 €
|
1,4 B | 2 |
| FY2027 |
1,05 €
1,04 € – 1,06 €
|
1,3 B | 5 |
Points Clés
Revenue grew 5,72% annually over 5 years — modest growth
Earnings grew 75,57% over the past year
ROE of 15,42% — decent returns on equity
Debt/Equity of 3,75 — high leverage
Generating 149,18M in free cash flow
P/E of 50,64 — premium valuation
Croissance
Revenue Growth (5Y)
5,72%
Revenue (1Y)5,74%
Earnings (1Y)75,57%
FCF Growth (3Y)N/A
Qualité
Return on Equity
15,42%
ROIC10,23%
Net Margin6,70%
Op. Margin33,75%
Sécurité
Debt / Equity
3,75
Current Ratio2,46
Interest Coverage2,52
Valorisation
P/E Ratio
50,64
P/B Ratio6,51
EV/EBITDA14,96
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,74% | Revenue Growth (3Y) | 5,31% |
| Earnings Growth (1Y) | 75,57% | Earnings Growth (3Y) | 23,18% |
| Revenue Growth (5Y) | 5,72% | Earnings Growth (5Y) | -9,63% |
| Profitability | |||
| Revenue (TTM) | 1,16B | Net Income (TTM) | 77,95M |
| ROE | 15,42% | ROA | 2,39% |
| Gross Margin | 55,48% | Operating Margin | 33,75% |
| Net Margin | 6,70% | Free Cash Flow (TTM) | 149,18M |
| ROIC | 10,23% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 3,75 | Current Ratio | 2,46 |
| Interest Coverage | 2,52 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 50,64 | P/B Ratio | 6,51 |
| P/S Ratio | 3,39 | PEG Ratio | 0,93 |
| EV/EBITDA | 14,96 | Dividend Yield | 0,00% |
| Market Cap | 3,95B | Enterprise Value | 5,87B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,16B | 1,10B | 1,05B | 1,00B | 931,48M |
| Net Income | 77,95M | 44,40M | 51,38M | -233,57M | 116,88M |
| EPS (Diluted) | 0,27 | 0,16 | 0,18 | -0,83 | 0,41 |
| Gross Profit | 645,53M | 602,30M | 577,16M | 557,00M | 518,67M |
| Operating Income | 392,77M | 297,63M | 276,69M | 248,35M | 256,73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,26B | 3,07B | 3,13B | 3,12B | 2,79B |
| Total Liabilities | 2,66B | 2,67B | 2,69B | 2,77B | 2,20B |
| Shareholders' Equity | 606,04M | 404,91M | 443,73M | 350,24M | 586,10M |
| Total Debt | 2,27B | 2,35B | 2,33B | 2,03B | 1,83B |
| Cash & Equivalents | 346,46M | 277,24M | 296,41M | 395,21M | 106,92M |
| Current Assets | 613,41M | 526,04M | 557,24M | 645,01M | 345,96M |
| Current Liabilities | 249,58M | 191,00M | 230,65M | 791,57M | 161,16M |